Resultado de búsqueda
Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues.
- Tissue Engineering and Regenerative Medicine International ...
Tissue Engineering and Regenerative Medicine International...
- Tissue Engineering and Regenerative Medicine International ...
La Ingeniería de tejidos, también conocida como medicina regenerativa, es la rama de la bioingeniería que se sirve de la combinación de células, métodos de ingeniería de materiales, bioquímica y fisicoquímica para mejorar o reemplazar funciones biológicas.
Tissue engineering evolved from the field of biomaterial s development and refers to the practice of combining scaffold s, cells, and biologically active molecules into functional tissues. The goal of tissue engineering is to assemble functional constructs that restore, maintain, or improve damaged tissues or whole organs.
This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs. [2] Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself.
Tissue Engineering and Regenerative Medicine International Society, TERMIS, (en español, Sociedad Internacional de Ingeniería de Tejidos y Medicina Regenerativa) es una sociedad científica internacional cuyo objetivo es la promoción en todo el mundo tanto de la ciencia como de la tecnología de la ingeniería de tejidos y la medicina ...
Tissue engineering (TE) is an interdisciplinary field in which knowledge from physics, chemistry, biological sciences, and engineering are combined to design, build, modify, raise, and maintain living tissues [1], with the aim of overcoming the intrinsic limits of traditional approaches based on transplants (lack of donors [2] and ...
